{"version":1,"type":"story","url":"https://digestai.news/story/warp-sciences-launches-u-s-based-cro-for-ai-driven-drug-research","json":"https://digestai.news/story/warp-sciences-launches-u-s-based-cro-for-ai-driven-drug-research.json","markdown":"https://digestai.news/story/warp-sciences-launches-u-s-based-cro-for-ai-driven-drug-research.md","slug":"warp-sciences-launches-u-s-based-cro-for-ai-driven-drug-research","headline":"Warp Sciences launches U.S.-based CRO for AI-driven drug research","summary":"The startup combines robotics and AI to accelerate drug discovery by automating lab experiments and generating real-world data for training AI models. Founded by Kevin Weil, Solomon Reisberg, Manohar Paluri, and DJ Patil, Warp aims to shorten the cycle from molecular design to testing while ensuring IP protection and sovereign biotechnology for customers. Its initial focus is on lead optimization analog synthesis, with human chemists guiding increasingly automated processes.\n\nThe company cites a 2024 BIO survey showing 74% of biotech firms use Chinese partners for preclinical and clinical services, framing its U.S.-based approach as a response to geopolitical and IP concerns. Backed by Lightspeed, Premji Invest, Mayfield, and angel investors including Brian Armstrong and Mike Krieger, Warp emphasizes customer-led discovery without developing its own drug pipeline. Early hires bring expertise from Genesis, Skild AI, Genentech, and Lawrence Livermore National Labs.","keyPoints":["Warp Sciences raises $215 million to build a U.S.-based chemistry CRO for AI-driven drug research","Combines robotics and AI to automate lab experiments and generate data for AI training","Focuses on lead optimization analog synthesis with human oversight and IP protection"],"whyItMatters":"Warp Sciences bridges AI and physical sciences by automating lab work, potentially speeding drug discovery while addressing geopolitical and IP risks for biotech firms.","category":{"slug":"robotics","name":"Robotics & Physical AI","url":"https://digestai.news/category/robotics"},"entities":{"companies":["Warp Sciences","Lightspeed","Premji Invest","Mayfield","Genesis","Skild AI"],"models":[],"people":["Kevin Weil","Mike Krieger","Brian Armstrong","Fidji Simo","Mark Chen","Sarah Friar"]},"firstPublishedAt":"2026-10-28T16:28:48Z","updatedAt":"2026-10-28T16:28:48Z","sourceCount":1,"hasPrimarySource":false,"sources":[{"outlet":"The Robot Report","title":"Warp Sciences emerges from stealth, to apply robotics to drug research","url":"https://therobotreport.com/warp-sciences-emerges-stealth-apply-robotics-drug-research","publishedAt":"2026-10-28T16:28:48Z","type":"press","primary":false,"lead":true}],"sourceNotes":null,"discussions":[],"thread":{"title":"AI Pharma Pioneer Kevin Weil's Warp Journey","url":"https://digestai.news/thread/kevin-weil-launches-ai-science-startup-with-215-million-bloomberg-reports","storyCount":2},"cite":{"text":"Digest AI, \"Warp Sciences launches U.S.-based CRO for AI-driven drug research\", 28 October 2026, https://digestai.news/story/warp-sciences-launches-u-s-based-cro-for-ai-driven-drug-research","publisher":"Digest AI","title":"Warp Sciences launches U.S.-based CRO for AI-driven drug research","datePublished":"2026-10-28T16:28:48Z","url":"https://digestai.news/story/warp-sciences-launches-u-s-based-cro-for-ai-driven-drug-research"},"generatedBy":"Written by Digest AI's editorial model from the linked sources; the sources are the record.","license":"Headlines, digests and key points are written by Digest AI and may be quoted with a link to the story page. Linked articles belong to their publishers. Terms: https://digestai.news/terms#reuse"}